Predict your next investment

Surface Ophthalmics company logo
HEALTHCARE | Drug Development
surfacepharma.com

See what CB Insights has to offer

Stage

Series B | Alive

Total Raised

$45M

Last Raised

$25M | 2 mos ago

About Surface Ophthalmics

Surface Pharmaceuticals is a drug development company working on treatments for dry eye and blepharitis. Surface's pipeline includes eye drops SURF-100 and SURF-200, which combine the generic medications mycophenolic acid and betamethasone, respectively, with Imprimis' delivery vehicle, Klarity, a topical opthalmic gel or solution. The company's third drug, SURF-300, combines the antibiotic doxycycline and omega-3 in an oral capsule.

Surface Ophthalmics Headquarter Location

5000 Hopyard Rd

Pleasanton, California, 94588,

United States

Latest Surface Ophthalmics News

Surface Ophthalmics: Raises $25M in Funding

Jul 26, 2021

Surface Ophthalmics Raises $25M in Funding Surface Ophthalmics , a Pleasanton CA-based pharmaceutical company, raised $25M in funding Investors included both new and existing investors made up of institutional, healthcare-focused, and other accredited investors The company intends to use the funds to advance its clinical programs in ocular diseases The company is a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases The company will be positioned to begin enrolling patients in Phase III clinical trials, targeting FDA approval These programs utilize Klarity® as the delivery vehicle, which is designed to enhance patient comfort as well as protect and rehabilitate the ocular surface Tags:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Surface Ophthalmics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Surface Ophthalmics is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Surface Ophthalmics Patents

Surface Ophthalmics has filed 2 patents.

The 3 most popular patent topics include:

  • Amines
  • Autoimmune diseases
  • Beta blockers
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/21/2018

H1 receptor antagonists, Amines, Beta blockers, Autoimmune diseases, Ethers

Application

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/21/2018

00/00/0000

Grant Date

00/00/0000

Title

Subscribe to see more

Related Topics

H1 receptor antagonists, Amines, Beta blockers, Autoimmune diseases, Ethers

Subscribe to see more

Status

Application

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.